LTIMindtree Limited

NSE LTIM.NS

LTIMindtree Limited EBITDA Margin for the year ending March 31, 2024: 19.96%

LTIMindtree Limited EBITDA Margin is 19.96% for the year ending March 31, 2024, a -0.62% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

LTIMindtree Limited EBITDA Margin for the year ending March 31, 2023 was 20.08%, a -47.68% change year over year.
LTIMindtree Limited EBITDA Margin for the year ending March 31, 2022 was 38.38%, a 58.72% change year over year.
LTIMindtree Limited EBITDA Margin for the year ending March 31, 2021 was 24.18%, a 11.55% change year over year.
LTIMindtree Limited EBITDA Margin for the year ending March 31, 2020 was 21.68%, a -5.85% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NSE: LTIM.NS

LTIMindtree Limited

CEO	Mr. Debashis Chatterjee
IPO Date	July 21, 2016
Location	India
Headquarters	Technology Tower 1
Employees	83,532
Sector	Finance
Industries Fintech Credit Cards & Payments E-commerce Enterprise Resource Planning (ERP) Hardware & Electronics Research & Consulting Software-as-a-Service (SaaS) Telehealth

Description

LTIMindtree Limited, a technology consulting and digital solutions company, provides information technology services and solutions in India, North America, Europe, the Asia Pacific, and internationally. The company operates through Banking, Financial Services & Insurance; Manufacturing; Energy & Utilities; High-Tech, Media & Entertainment; and CPG, Retail, Pharma & Others segments. It offers application development, maintenance and outsourcing, enterprise, infrastructure management, testing, digital, and platform-based solutions. LTIMindtree Limited has a strategic collaboration agreement with Amazon Web Services, Inc.; and a strategic partnership with eClinicalHealth Limited to enhance digital innovation in clinical trials management process for patient centric drug development. The company was formerly known as Larsen & Toubro Infotech Limited and changed its name to LTIMindtree Limited in November 2022. The company was incorporated in 1996 and is based in Mumbai, India. LTIMindtree Limited operates as a subsidiary of Larsen & Toubro Limited.

Key trends

Past 5 years